TGTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $781,496.86

TG Therapeutics Insider Trading History Chart

TG Therapeutics Share Price & Price History

^$38.32

▲ +0.11 (0.29%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

TG Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/6/2025	Sean A. Power	CFO	Sell	10,021	$28.53	$285,899.13	660,611
1/3/2025	Sean A. Power	CFO	Sell	11,337	$30.29	$343,397.73	670,632
11/11/2024	Sagar Lonial	Director	Sell	5,000	$30.44	$152,200.00	100,195
3/12/2024	Laurence N. Charney	Director	Sell	22,000	$15.97	$351,340.00	215,229
1/5/2024	Laurence N. Charney	Director	Sell	17,500	$19.03	$333,025.00	237,229
1/3/2024	Sean A. Power	CFO	Sell	47,867	$16.91	$809,430.97	606,969
8/11/2023	Michael S. Weiss	CEO	Buy	100,000	$10.13	$1,013,000.00	12,073,021
6/23/2023	Sagar Lonial	Director	Sell	34,854	$23.37	$814,537.98	93,878
6/2/2023	Sean A. Power	CFO	Sell	73,647	$26.70	$1,966,374.90	654,836
1/6/2023	Yann Echelard	Director	Buy	9,000	$10.64	$95,760.00	201,848
1/4/2023	Laurence N. Charney	Director	Sell	30,000	$11.10	$333,000.00	234,729

SEC Filings (Institutional Ownership Changes) for TG Therapeutics (NASDAQ:TGTX)

58.58% of TG Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

TG Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	Grimes & Company Inc.	6,100	$0.24M	0.0%	N/A	0.004%
4/16/2025	Avaii Wealth Management LLC	29,300	$1.16M	0.6%	-3.6%	0.019%
4/15/2025	USA Financial Formulas	1,436	$57K	0.0%	N/A	0.001%
4/15/2025	Assenagon Asset Management S.A.	6,172	$0.24M	0.0%	-94.0%	0.004%
4/15/2025	GAMMA Investing LLC	4,543	$0.18M	0.0%	+77.7%	0.003%
4/14/2025	Yousif Capital Management LLC	50,532	$1.99M	0.0%	-2.0%	0.032%
4/14/2025	Daymark Wealth Partners LLC	45,500	$1.79M	0.1%	+9.6%	0.029%
4/14/2025	First Citizens Bank & Trust Co.	5,355	$0.21M	0.0%	N/A	0.003%
4/10/2025	Hennion & Walsh Asset Management Inc.	95,171	$3.75M	0.2%	-2.5%	0.061%
4/9/2025	NBC Securities Inc.	824	$32K	0.0%	+82,300.0%	0.001%
4/8/2025	Rhumbline Advisers	381,854	$15.06M	0.0%	-0.3%	0.243%
4/7/2025	GAMMA Investing LLC	179,130	$7.06M	0.0%	+6,905.5%	0.114%
3/24/2025	Wellington Management Group LLP	63,513	$1.91M	0.0%	-13.4%	0.040%
3/18/2025	California State Teachers Retirement System	137,002	$4.12M	0.0%	-1.0%	0.087%
3/18/2025	CWC Advisors LLC.	13,700	$0.41M	0.4%	-15.2%	0.009%
3/17/2025	NorthCrest Asset Manangement LLC	14,890	$0.45M	0.0%	N/A	0.009%
2/21/2025	Vermillion Wealth Management Inc.	1,000	$30K	0.0%	N/A	0.001%
2/20/2025	Mackenzie Financial Corp	8,888	$0.27M	0.0%	-46.1%	0.006%
2/18/2025	Connecticut Wealth Management LLC	14,782	$0.45M	0.0%	-46.8%	0.009%
2/18/2025	Castleark Management LLC	211,370	$6.36M	0.2%	+25.2%	0.136%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	272,370	$8.20M	0.0%	-7.3%	0.175%
2/17/2025	Soleus Capital Management L.P.	2,681,242	$80.71M	5.1%	+5.8%	1.722%
2/17/2025	Wexford Capital LP	14,000	$0.42M	0.1%	N/A	0.009%
2/17/2025	Two Sigma Advisers LP	10,700	$0.32M	0.0%	-95.3%	0.007%
2/17/2025	Two Sigma Investments LP	606,208	$18.25M	0.0%	-43.0%	0.389%
2/17/2025	Rafferty Asset Management LLC	331,412	$9.98M	0.0%	-2.7%	0.213%
2/17/2025	Redwood Investments LLC	94,554	$2.85M	0.8%	+0.9%	0.061%
2/17/2025	ProShare Advisors LLC	41,955	$1.26M	0.0%	+44.7%	0.027%
2/17/2025	Man Group plc	9,589	$0.29M	0.0%	N/A	0.006%
2/17/2025	Nicholas Investment Partners LP	84,147	$2.53M	0.2%	-23.3%	0.054%
2/17/2025	Nuveen Asset Management LLC	1,798,989	$54.15M	0.0%	-11.4%	1.156%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	92,683	$2.81M	0.0%	+3.2%	0.060%
2/17/2025	Lazard Asset Management LLC	6,376	$0.19M	0.0%	-31.8%	0.004%
2/17/2025	Integral Health Asset Management LLC	150,000	$4.52M	0.4%	N/A	0.096%
2/17/2025	J. Goldman & Co LP	8,036	$0.24M	0.0%	-81.2%	0.005%
2/17/2025	Jacobs Levy Equity Management Inc.	84,589	$2.55M	0.0%	-53.1%	0.054%
2/17/2025	Gotham Asset Management LLC	50,949	$1.53M	0.0%	-55.8%	0.033%
2/17/2025	Deutsche Bank AG	147,020	$4.43M	0.0%	+40.4%	0.094%
2/17/2025	Cornerstone Select Advisors LLC	63,270	$1.90M	1.8%	N/A	0.041%
2/17/2025	Cetera Investment Advisers	52,199	$1.57M	0.0%	-1.0%	0.034%
2/17/2025	Brevan Howard Capital Management LP	15,042	$0.45M	0.0%	N/A	0.010%
2/17/2025	Captrust Financial Advisors	7,562	$0.23M	0.0%	-75.1%	0.005%
2/17/2025	Balyasny Asset Management L.P.	9,100	$0.27M	0.0%	N/A	0.006%
2/17/2025	Baird Financial Group Inc.	56,129	$1.69M	0.0%	+7.6%	0.036%
2/17/2025	Bank of America Corp DE	230,939	$6.95M	0.0%	-86.4%	0.148%
2/17/2025	BNP Paribas Financial Markets	59,710	$1.80M	0.0%	-49.4%	0.038%
2/17/2025	Ameriprise Financial Inc.	459,037	$13.80M	0.0%	-0.1%	0.295%
2/17/2025	Algert Global LLC	49,061	$1.48M	0.0%	-52.9%	0.032%
2/17/2025	683 Capital Management LLC	697,000	$20.98M	1.3%	-38.6%	0.448%
2/14/2025	Freestone Grove Partners LP	7,433	$0.22M	0.0%	N/A	0.005%
2/14/2025	PDT Partners LLC	32,187	$0.97M	0.1%	-46.9%	0.021%
2/14/2025	Lido Advisors LLC	7,680	$0.23M	0.0%	N/A	0.005%
2/14/2025	Northern Trust Corp	1,532,929	$46.14M	0.0%	+8.6%	0.985%
2/14/2025	The Manufacturers Life Insurance Company	75,327	$2.27M	0.0%	-4.9%	0.048%
2/14/2025	Artia Global Partners LP	54,515	$1.64M	0.6%	N/A	0.035%
2/14/2025	Boothbay Fund Management LLC	85,360	$2.57M	0.1%	N/A	0.055%
2/14/2025	Susquehanna Fundamental Investments LLC	9,650	$0.29M	0.0%	N/A	0.006%
2/14/2025	Virtus ETF Advisers LLC	11,393	$0.34M	0.1%	-42.0%	0.007%
2/14/2025	Gilder Gagnon Howe & Co. LLC	81,292	$2.45M	0.0%	+25.3%	0.052%
2/14/2025	Voya Investment Management LLC	273,739	$8.24M	0.0%	+398.0%	0.176%
2/14/2025	Penn Capital Management Company LLC	351,408	$10.58M	1.0%	N/A	0.226%
2/14/2025	Syon Capital LLC	9,157	$0.28M	0.0%	N/A	0.006%
2/14/2025	Hood River Capital Management LLC	1,455,323	$43.81M	0.6%	-10.7%	0.935%
2/14/2025	Price T Rowe Associates Inc. MD	297,101	$8.94M	0.0%	+264.5%	0.191%
2/14/2025	State of Tennessee Department of Treasury	59,883	$1.80M	0.0%	+28.4%	0.038%
2/14/2025	Tower Research Capital LLC TRC	32,498	$0.98M	0.0%	+937.6%	0.021%
2/14/2025	MYDA Advisors LLC	55,000	$1.66M	0.4%	+37.5%	0.035%
2/14/2025	MetLife Investment Management LLC	84,360	$2.54M	0.0%	+4.7%	0.054%
2/14/2025	First Trust Advisors LP	275,496	$8.29M	0.0%	+871.7%	0.177%
2/14/2025	Commerce Bank	6,789	$0.20M	0.0%	N/A	0.004%
2/14/2025	Altium Capital Management LLC	95,000	$2.86M	0.8%	N/A	0.061%
2/13/2025	CANADA LIFE ASSURANCE Co	128,637	$3.87M	0.0%	-2.8%	0.083%
2/13/2025	NewEdge Advisors LLC	6,928	$0.21M	0.0%	+4,549.7%	0.004%
2/13/2025	EAM Investors LLC	128,923	$3.88M	0.6%	-26.7%	0.083%
2/13/2025	Guggenheim Capital LLC	41,461	$1.25M	0.0%	-26.4%	0.027%
2/13/2025	XTX Topco Ltd	13,304	$0.40M	0.0%	N/A	0.009%
2/13/2025	Barclays PLC	317,563	$9.56M	0.0%	-8.5%	0.204%
2/13/2025	Summit Investment Advisors Inc.	14,606	$0.44M	0.4%	+3.3%	0.009%
2/13/2025	Synovus Financial Corp	19,500	$0.59M	0.0%	-2.0%	0.013%
2/13/2025	Raymond James Financial Inc.	481,989	$14.51M	0.0%	N/A	0.310%
2/13/2025	Advisory Services Network LLC	10,359	$0.31M	0.0%	+19.5%	0.007%
2/13/2025	Legal & General Group Plc	391,388	$11.78M	0.0%	-1.8%	0.251%
2/13/2025	Invesco Ltd.	929,743	$27.99M	0.0%	+1.2%	0.597%
2/13/2025	Bank of Montreal Can	20,016	$0.60M	0.0%	+7.3%	0.013%
2/13/2025	Shakespeare Wealth Management LLC	7,398	$0.22M	0.1%	N/A	0.005%
2/13/2025	Federated Hermes Inc.	130,688	$3.93M	0.0%	+25.9%	0.084%
2/13/2025	Quadrant Capital Group LLC	1,686	$51K	0.0%	+137.1%	0.001%
2/13/2025	Russell Investments Group Ltd.	34,706	$1.05M	0.0%	+323.2%	0.022%
2/13/2025	Envestnet Asset Management Inc.	50,111	$1.51M	0.0%	+11.4%	0.032%
2/13/2025	Rhenman & Partners Asset Management AB	262,500	$7.90M	0.8%	+53.1%	0.169%
2/13/2025	Wells Fargo & Company MN	331,403	$9.98M	0.0%	+85.4%	0.213%
2/12/2025	Landscape Capital Management L.L.C.	23,428	$0.71M	0.1%	N/A	0.015%
2/12/2025	Pitcairn Co.	11,745	$0.35M	0.0%	N/A	0.008%
2/12/2025	Headlands Technologies LLC	21,653	$0.65M	0.1%	+494.5%	0.014%
2/12/2025	Geode Capital Management LLC	3,193,505	$96.15M	0.0%	-0.4%	2.052%
2/12/2025	Franklin Resources Inc.	97,538	$2.94M	0.0%	-24.4%	0.063%
2/12/2025	Alliancebernstein L.P.	174,020	$5.24M	0.0%	-10.1%	0.112%
2/12/2025	Wellington Management Group LLP	63,513	$1.91M	0.0%	-13.4%	0.041%
2/12/2025	O Shaughnessy Asset Management LLC	8,617	$0.26M	0.0%	N/A	0.006%
2/12/2025	Clearbridge Investments LLC	1,835,127	$55.24M	0.0%	N/A	1.179%

Data available starting January 2016

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.

Today's Range

Now: $38.32

$37.59

$38.92

50 Day Range

MA: $36.20

$28.53

$42.99

52 Week Range

Now: $38.32

$12.93

$43.32

Volume

1,074,546 shs

Average Volume

3,108,359 shs

Market Capitalization

$6.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.14

Who are the company insiders with the largest holdings of TG Therapeutics?: TG Therapeutics' top insider investors include:
Michael S Weiss (CEO)
Sean A Power (CFO)
Laurence N Charney (Director)
Sagar Lonial (Director)
Learn More about top insider investors at TG Therapeutics.
Who are the major institutional investors of TG Therapeutics?: TG Therapeutics' top institutional shareholders include:
Rhumbline Advisers — 0.24%
GAMMA Investing LLC — 0.11%
Hennion & Walsh Asset Management Inc. — 0.06%
Yousif Capital Management LLC — 0.03%
Daymark Wealth Partners LLC — 0.03%
Avaii Wealth Management LLC — 0.02%
Learn More about top institutional investors of TG Therapeutics stock.
Which institutional investors are selling TG Therapeutics stock?: In the previous quarter, TGTX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Hennion & Walsh Asset Management Inc.
Rhumbline Advisers
Avaii Wealth Management LLC
Yousif Capital Management LLC
In the previous year, company insiders that have sold TG Therapeutics company stock include:
Michael S Weiss (CEO)
Sean A Power (CFO)
Learn More investors selling TG Therapeutics stock.
Which institutional investors are buying TG Therapeutics stock?: In the last quarter, TGTX stock was bought by institutional investors including:
GAMMA Investing LLC
First Citizens Bank & Trust Co.
Daymark Wealth Partners LLC
GAMMA Investing LLC
USA Financial Formulas
NBC Securities Inc.